Paul Tudor Jones Edwards Lifesciences Corp Put Options Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $226,860 - $356,364	3,800 Added 100.0%	7,600 $501,000
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $320,340 - $358,378	3,800 New	3,800 $351,000
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $419,628 - $528,768	-6,800 Reduced 67.33%	3,300 $251,000
Q3 2023 Nov 15, 2023	BUY	$69.28 - $93.38 $263,264 - $354,844	3,800 Added 60.32%	10,100 $699,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $512,883 - $594,279	6,300 New	6,300 $594,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $1.28 Million - $1.64 Million	18,700 Added 259.72%	25,900 $1.93 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $74,133 - $96,561	900 Added 14.29%	7,200 $595,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $389,250 - $577,215	4,500 Added 250.0%	6,300 $600,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $122,351 - $154,008	-1,200 Reduced 40.0%	1,800 $213,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $319,110 - $392,040	3,000 New	3,000 $390,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.